Celyad (voorheen Cardio3 BioSciences SA)

Beleggen in aandelen beurs Brussel, BEL 20, lokale fondsen, etc.
Plaats reactie
Gebruikersavatar
Lama Daila
Forum actieveling
Forum actieveling
Berichten: 951
Lid geworden op: 20 Jul 2017 10:53
waarderingen: 1235
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lama Daila » 12 Apr 2018 18:14

https://www.thelincolnianonline.com/201 ... lysts.html

Zacks: Celyad SA (CYAD) Receives Consensus Rating of “Strong Buy” from Analysts


Celyad SA (NASDAQ:CYAD) has received an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 12 month consensus price target of $74.00 for the company, according to Zacks. Zacks has also assigned Celyad an industry rank of 190 out of 265 based on the ratings given to related companies.
How to Become a New Pot Stock Millionaire
Separately, ValuEngine lowered shares of Celyad from a “hold” rating to a “sell” rating in a report on Friday, December 1st.


Large investors have recently bought and sold shares of the business. Deutsche Bank AG purchased a new stake in Celyad in the fourth quarter valued at $150,000. Renaissance Technologies LLC purchased a new stake in Celyad in the fourth quarter valued at $227,000. Jane Street Group LLC purchased a new stake in Celyad in the fourth quarter valued at $260,000. Finally, Victory Capital Management Inc. boosted its holdings in Celyad by 36.5% in the fourth quarter. Victory Capital Management Inc. now owns 443,902 shares of the company’s stock valued at $19,483,000 after purchasing an additional 118,590 shares during the last quarter. 4.73% of the stock is currently owned by institutional investors.
CYAD stock traded up $1.61 during trading hours on Tuesday, reaching $35.71. 3,009 shares of the company’s stock traded hands, compared to its average volume of 4,067. Celyad has a one year low of $20.51 and a one year high of $64.75.
Lampi liked last!
https://twitter.com/lama_daila


Gebruikersavatar
Lama Daila
Forum actieveling
Forum actieveling
Berichten: 951
Lid geworden op: 20 Jul 2017 10:53
waarderingen: 1235
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lama Daila » 13 Apr 2018 08:10

https://twitter.com/biotechradar/status ... 39008?s=21

CCBD8606-4B0F-4B13-BB8A-15DF76A0BC2E.jpeg
U kunt de afbeeldingen in deze bijlage niet bekijken, registreer hier en bekijk de bijlage.
Lampi liked last!
https://twitter.com/lama_daila

beurssukkel
Forum actieveling
Forum actieveling
Berichten: 304
Lid geworden op: 03 Nov 2015 16:17
waarderingen: 74
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor beurssukkel » 13 Apr 2018 16:30

Vandaag 2 aankopen van te zwaar afgestrafte aandelen, één hiervan is
CELYAD


Koersdoelen tussen 36 en 75€
Lampi liked last!

Lampi
Forum actieveling
Forum actieveling
Berichten: 365
Lid geworden op: 21 Jun 2017 19:29
waarderingen: 97
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lampi » 19 Apr 2018 11:43


Lampi
Forum actieveling
Forum actieveling
Berichten: 365
Lid geworden op: 21 Jun 2017 19:29
waarderingen: 97
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lampi » 19 Apr 2018 19:53


Lampi
Forum actieveling
Forum actieveling
Berichten: 365
Lid geworden op: 21 Jun 2017 19:29
waarderingen: 97
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lampi » 20 Apr 2018 12:43


Gebruikersavatar
Lama Daila
Forum actieveling
Forum actieveling
Berichten: 951
Lid geworden op: 20 Jul 2017 10:53
waarderingen: 1235
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lama Daila » 20 Apr 2018 13:02

Lampi schreef:https://twitter.com/LaBourseEtLaVie/status/986584444084596736
interview met de CEO :)

Ja, had ik ook gezien. Het is wel de CFO.
Kapitaalsverhoging voor de zomer (maar geen echte haast).
https://twitter.com/lama_daila

Lampi
Forum actieveling
Forum actieveling
Berichten: 365
Lid geworden op: 21 Jun 2017 19:29
waarderingen: 97
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lampi » 20 Apr 2018 13:03

Lama Daila schreef:
Lampi schreef:https://twitter.com/LaBourseEtLaVie/status/986584444084596736
interview met de CEO :)

Ja, had ik ook gezien. Het is wel de CFO.
Kapitaalsverhoging voor de zomer (maar geen echte haast).

idd, was te verwachten, maar kans om bij te kopen en BEP naar beneden te halen voor mij dan toch...

Lampi
Forum actieveling
Forum actieveling
Berichten: 365
Lid geworden op: 21 Jun 2017 19:29
waarderingen: 97
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor Lampi » 23 Apr 2018 11:58


duca
Forum verkenner
Forum verkenner
Berichten: 46
Lid geworden op: 07 Mar 2017 19:33
waarderingen: 32
Contact:

Re: Celyad (voorheen Cardio3 BioSciences SA)

Berichtdoor duca » 27 Apr 2018 09:18

kanker genezen zonder chemo, dat is toch topnieuws !

https://www.reuters.com/article/brief-c ... SFWN1S40JN


F-Celyad's CYAD-01 Induced Complete Remission In Relapsed/Refractory AML Patient

April 27 (Reuters) - CELYAD SA CYAD.BR :
* HAEMATOLOGICA PUBLISHES CELYAD THINK STUDY CASE REPORT OF
CYAD-01 INDUCED COMPLETE REMISSION IN RELAPSED/REFRACTORY AML
PATIENT
* PATIENT ACHIEVED A COMPLETE MOLECULAR REMISSION AND
REMAINS IN
REMISSION 9 MONTHS POST STUDY ENROLLMENT
* CYAD-01 WAS WELL TOLERATED WITH NO SIGNIFICANT TOXICITIES
* DEMONSTRATED 1ST OBJECTIVE RESPONSE TO ANY CAR-T IN
RELAPSED/REFRACTORY AML WITHOUT PRECONDITIONING CHEMOTHERAPY
HIGHLIGHTS POTENTIAL OF CYAD-01 AS TREATMENT FOR AML
Lama Daila liked last!